Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line < em > Helicobacter Pylori < /em > Eradication Therapy Administered with Bismuth

CONCLUSION: In eradication-naive patients, eradication success rates for 7-day first-line triple therapy regimen exceeded 82% with bismuth administration. In clarithromycin-resistant patients, neither tegoprazan 50 mg nor lansoprazole 30 mg achieved acceptable eradication rates when administered twice daily for 7 days.PMID:34296548 | PMC:PMC8298865 | DOI:10.3349/ymj.2021.62.8.708

Source: Yonsei Medical Journal - July 23, 2021 Category: Universities & Medical Training Authors: Ji Yeon Kim Sun Young Lee Hyobin Kim Jeong Hwan Kim In Kyung Sung Hyung Seok Park Source Type: research